X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES PANACEA BIOTECH SUVEN LIFESCIENCES/
PANACEA BIOTECH
 
P/E (TTM) x 21.3 -5.8 - View Chart
P/BV x 4.2 3.1 133.0% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SUVEN LIFESCIENCES   PANACEA BIOTECH
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
PANACEA BIOTECH
Mar-18
SUVEN LIFESCIENCES/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs251364 68.9%   
Low Rs155129 120.1%   
Sales per share (Unadj.) Rs49.196.8 50.8%  
Earnings per share (Unadj.) Rs9.7-12.4 -78.3%  
Cash flow per share (Unadj.) Rs11.4-2.9 -399.4%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.350.4 119.6%  
Shares outstanding (eoy) m127.2861.25 207.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.5 162.1%   
Avg P/E ratio x20.9-19.9 -105.1%  
P/CF ratio (eoy) x17.8-86.4 -20.6%  
Price / Book Value ratio x3.44.9 68.8%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,82515,101 171.0%   
No. of employees `0001.12.5 43.4%   
Total wages/salary Rs m6131,516 40.4%   
Avg. sales/employee Rs Th5,832.62,401.9 242.8%   
Avg. wages/employee Rs Th571.5614.2 93.1%   
Avg. net profit/employee Rs Th1,153.8-307.9 -374.7%   
INCOME DATA
Net Sales Rs m6,2535,928 105.5%  
Other income Rs m23382 282.7%   
Total revenues Rs m6,4856,010 107.9%   
Gross profit Rs m1,982845 234.4%  
Depreciation Rs m213585 36.4%   
Interest Rs m461,006 4.6%   
Profit before tax Rs m1,955-664 -294.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71899 728.4%   
Profit after tax Rs m1,237-760 -162.7%  
Gross profit margin %31.714.3 222.3%  
Effective tax rate %36.7-14.9 -247.2%   
Net profit margin %19.8-12.8 -154.3%  
BALANCE SHEET DATA
Current assets Rs m5,6225,603 100.3%   
Current liabilities Rs m1,1686,910 16.9%   
Net working cap to sales %71.2-22.0 -323.2%  
Current ratio x4.80.8 593.8%  
Inventory Days Days81206 39.6%  
Debtors Days Days3684 42.9%  
Net fixed assets Rs m3,3259,941 33.4%   
Share capital Rs m12761 207.7%   
"Free" reserves Rs m7,5473,026 249.4%   
Net worth Rs m7,6743,087 248.6%   
Long term debt Rs m145,707 0.2%   
Total assets Rs m9,13516,076 56.8%  
Interest coverage x43.20.3 12,701.6%   
Debt to equity ratio x01.8 0.1%  
Sales to assets ratio x0.70.4 185.6%   
Return on assets %14.01.5 918.6%  
Return on equity %16.1-24.6 -65.5%  
Return on capital %26.03.9 664.7%  
Exports to sales %024.0 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA1,424 0.0%   
Imports (cif) Rs mNA1,040 0.0%   
Fx inflow Rs m5,0661,600 316.6%   
Fx outflow Rs m2,0011,131 176.9%   
Net fx Rs m3,065469 654.1%   
CASH FLOW
From Operations Rs m6991,180 59.3%  
From Investments Rs m-6553 -1.1%  
From Financial Activity Rs m-577-1,644 35.1%  
Net Cashflow Rs m11690 129.7%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.6 154.7%  
Shareholders   37,287 10,259 363.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 300 Points Higher; Energy and Metal Stocks Witness Buying(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jun 25, 2019 03:37 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS